Cytisine treatment for helping smokers quit and its effects on heart health

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the effectiveness of cytisine, a plant-derived alkaloid, in aiding smoking cessation among adult smokers and users of alternative nicotine products. The study focuses on a 25-day treatment regimen and assesses its impact on cardiovascular function, including arterial stiffness and endothelial health. Additionally, it aims to track relapse rates, treatment side effects, and any new cardiovascular events during and after the treatment period. Participants will be recruited from a smoking cessation unit at a cardiology department.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Smokers willing to participate

Exclusion Criteria:

* history of coronary artery disease, active malignancy, history of severe liver and renal failure, history of autoimmune disease.

Where it's running

• Attikkon University Hospital
  Athens, Haidari, Greece Recruiting

Study contacts

• Study coordinator: Ignatios Ikonomidis, MD;PhD
• Email: ignoik@gmail.com
• Phone: 00306944805732

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How Lipoprotein(a) affects artery stiffness, blood vessel lining, and heart muscle movement

  This project will see if higher Lipoprotein(a) levels are linked to stiffer arteries, worse endothelial function, and changes in left atrial and left ventricular motion in adults 18–75.

  Recruiting at 2 sites University of Athens · Athens, Attica and 1 other locations · NCT07324902

• Quitting Matters: a smoking quit program for people living with HIV

  This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT06883097

• Understanding the role of glycocalyx integrity in preventing major cardiovascular events

  This study is looking to see if the health of a protective layer in blood vessels can help prevent serious heart problems in people getting routine check-ups.

  Recruiting University of Athens · Athens, Attica · NCT04646252

• Evaluating vascular aging after COVID-19 infection

  This study is testing how COVID-19 affects blood vessel health and aging in adults by checking their heart and blood vessel function six and twelve months after infection.

  Recruiting at 3 sites Assistance Publique - Hôpitaux de Paris · Nancy and 2 other locations · NCT04558450

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

• Nicotine Orodispersible Tablet to Relieve Cravings in Smokers

  A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.

  Recruiting Phase 2 Kenvue Brands LLC · Mississauga, Ontario · NCT07893158

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.